Financial News
Biden administration asserts power to seize drug patents in move to slash high prices
December 07, 2023 at 09:00 AM EST
The Biden administration unveiled a new framework outlining the factors federal agencies should consider in determining whether to use march-in rights.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
